US Consumer Prices Rise in Line With Expectations in November as US Equity Futures Rise Pre-Bell

MT Newswires Live12-11

US equity futures were higher pre-bell Wednesday as traders digested the US November consumer price index report.

Dow Jones Industrial Average futures gained 0.2%, S&P 500 futures increased 0.4%, and Nasdaq futures were up 0.6%.

Oil prices were higher, with front-month global benchmark North Sea Brent crude up 1.2% at $73.04 per barrel and US West Texas Intermediate crude up 1.3% at $69.48 per barrel.

The US November consumer price index report, released at 8:30 am ET, showed a 0.3% increase in consumer prices for November, in line with estimates compiled by Bloomberg, following 0.2% growth previously.

In other world markets, Japan's Nikkei closed 0.01% higher, Hong Kong's Hang Seng ended 0.8% lower, and China's Shanghai Composite finished 0.3% higher. Meanwhile, UK's FTSE 100 lost 0.9%, Germany's DAX 30 index gained 0.1%, France's CAC 40 gained 0.4% and Spain's IBEX 35 fell 0.3% in Europe's early afternoon session.

In equities, Candel Therapeutics (CADL) shares climbed by more than 168% in premarket trading after the biopharmaceutical company said a phase 3 trial of CAN-2409 to treat localized prostate cancer met its primary endpoint.

On the losing side, Q32 Bio (QTTB) shares slumped 65% after the company said late Tuesday its phase 2a trial of a treatment candidate for atopic dermatitis failed to meet its primary endpoint. ImmunityBio (IBRX) dropped 31% after the company priced a 33.3-million-share stock offering at $3 per share for expected proceeds of about $100 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment